{
 "drug": "Sumatriptan Nasal Spray",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "09/08/2025",
 "dayN": 351,
 "cat": "Neurology",
 "companies": [
  "Prasco Laboratories"
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "09/08/2025",
   "update_type": "New",
   "initial_posting_date": "09/08/2025",
   "package_ndc": "66993-081-69",
   "generic_name": "Sumatriptan Nasal Spray",
   "contact_info": "866-525-0688",
   "related_info": "This product discontinuation is a business-related decision. The anticipated date that Prasco will cease distribution of the product is approximately February 28, 2026.",
   "openfda": {
    "application_number": [
     "NDA020626"
    ],
    "brand_name": [
     "SUMATRIPTAN"
    ],
    "generic_name": [
     "SUMATRIPTAN"
    ],
    "manufacturer_name": [
     "Prasco Laboratories"
    ],
    "product_ndc": [
     "66993-081",
     "66993-082"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "NASAL"
    ],
    "substance_name": [
     "SUMATRIPTAN"
    ],
    "rxcui": [
     "313159",
     "314227"
    ],
    "spl_id": [
     "c3c253a9-c0e5-4aa2-927e-8777ee89aa48"
    ],
    "spl_set_id": [
     "f63e616b-ae0c-432b-badc-8c45023aa725"
    ],
    "package_ndc": [
     "66993-081-69",
     "66993-082-69"
    ],
    "nui": [
     "N0000175763",
     "N0000175764",
     "N0000175765"
    ],
    "pharm_class_moa": [
     "Serotonin 1b Receptor Agonists [MoA]",
     "Serotonin 1d Receptor Agonists [MoA]"
    ],
    "pharm_class_epc": [
     "Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]"
    ],
    "unii": [
     "8R78F6L9VO"
    ]
   },
   "update_date": "09/08/2025",
   "therapeutic_category": [
    "Neurology"
   ],
   "dosage_form": "Nasal Spray",
   "presentation": "Imitrex, Nasal Spray, 5 mg/100 uL (NDC 66993-081-69)",
   "company_name": "Prasco Laboratories",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "09/08/2025",
   "update_type": "New",
   "initial_posting_date": "09/08/2025",
   "package_ndc": "66993-082-69",
   "generic_name": "Sumatriptan Nasal Spray",
   "contact_info": "866-525-0688",
   "related_info": "This product discontinuation is a business-related decision. The anticipated date that Prasco will cease distribution of the product is approximately March 16, 2026.",
   "openfda": {
    "application_number": [
     "NDA020626"
    ],
    "brand_name": [
     "SUMATRIPTAN"
    ],
    "generic_name": [
     "SUMATRIPTAN"
    ],
    "manufacturer_name": [
     "Prasco Laboratories"
    ],
    "product_ndc": [
     "66993-082",
     "66993-081"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "NASAL"
    ],
    "substance_name": [
     "SUMATRIPTAN"
    ],
    "rxcui": [
     "313159",
     "314227"
    ],
    "spl_id": [
     "c3c253a9-c0e5-4aa2-927e-8777ee89aa48"
    ],
    "spl_set_id": [
     "f63e616b-ae0c-432b-badc-8c45023aa725"
    ],
    "package_ndc": [
     "66993-081-69",
     "66993-082-69"
    ],
    "nui": [
     "N0000175763",
     "N0000175764",
     "N0000175765"
    ],
    "pharm_class_moa": [
     "Serotonin 1b Receptor Agonists [MoA]",
     "Serotonin 1d Receptor Agonists [MoA]"
    ],
    "pharm_class_epc": [
     "Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]"
    ],
    "unii": [
     "8R78F6L9VO"
    ]
   },
   "update_date": "09/08/2025",
   "therapeutic_category": [
    "Neurology"
   ],
   "dosage_form": "Nasal Spray",
   "presentation": "Imitrex, Nasal Spray, 20 mg/100 uL (NDC 66993-082-69)",
   "company_name": "Prasco Laboratories",
   "status": "To Be Discontinued"
  }
 ]
}